These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9608207)

  • 21. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
    Kim JR; Nandy A; Maji AK; Addy M; Dondorp AM; Day NP; Pukrittayakamee S; White NJ; Imwong M
    PLoS One; 2012; 7(7):e39645. PubMed ID: 22808048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the relapse risk of Plasmodium vivax in Iran under national chemotherapy scheme using a novel method.
    Haghdoost AA; Mazhari S; Bahaadini K
    J Vector Borne Dis; 2006 Dec; 43(4):168-72. PubMed ID: 17175701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid immunochromatography-based detection of mixed-species malaria infection in Pakistan.
    Beg MA; Ali SS; Haqqee R; Khan MA; Qasim Z; Hussain R; Smego RA
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):562-4. PubMed ID: 16124417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium vivax malaria presenting with skin rash--a case report.
    Zaki SA; Shanbag P
    J Vector Borne Dis; 2011 Dec; 48(4):245-6. PubMed ID: 22297289
    [No Abstract]   [Full Text] [Related]  

  • 26. Chloroquine-resistant Plasmodium vivax malaria in Peru.
    Ruebush TK; Zegarra J; Cairo J; Andersen EM; Green M; Pillai DR; Marquiño W; Huilca M; Arévalo E; Garcia C; Solary L; Kain KC
    Am J Trop Med Hyg; 2003 Nov; 69(5):548-52. PubMed ID: 14695094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
    Nicolas X; Granier H; Martin J; Klotz F
    Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital based study of malaria in Ratnagiri district, Maharashtra.
    Mishra G
    J Vector Borne Dis; 2003; 40(3-4):109-11. PubMed ID: 15119081
    [No Abstract]   [Full Text] [Related]  

  • 29. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
    Imwong M; Snounou G; Pukrittayakamee S; Tanomsing N; Kim JR; Nandy A; Guthmann JP; Nosten F; Carlton J; Looareesuwan S; Nair S; Sudimack D; Day NP; Anderson TJ; White NJ
    J Infect Dis; 2007 Apr; 195(7):927-33. PubMed ID: 17330781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
    Kocken CH; van der Wel A; Arbe-Barnes S; Brun R; Matile H; Scheurer C; Wittlin S; Thomas AW
    Exp Parasitol; 2006 Jul; 113(3):197-200. PubMed ID: 16458301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing scenario of malaria: a study at Calcutta.
    Hazra BR; Chowdhury RS; Saha SK; Ghosh MB; Mazumder AK
    Indian J Malariol; 1998 Jun; 35(2):111-6. PubMed ID: 10448229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Plasmodium falciparum in an endemic area in Calcutta.
    Mandal B; Mitra NK; Mukhopadhyay AK; Mukherjee H; Hati AK
    J Indian Med Assoc; 1998 Nov; 96(11):328-9. PubMed ID: 10218316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal failure in Plasmodium vivax malaria.
    Prakash J; Singh AK; Kumar NS; Saxena RK
    J Assoc Physicians India; 2003 Mar; 51():265-7. PubMed ID: 12839348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chloroquine-resistant Plasmodium vivax from Lombok.
    McCullough TJ; Rajabalendaran N; Kirubakaran M; Mollison LC
    Med J Aust; 1993 Aug; 159(3):211. PubMed ID: 8380027
    [No Abstract]   [Full Text] [Related]  

  • 36. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria.
    Khatri TD
    J Assoc Physicians India; 2002 Mar; 50():458-9. PubMed ID: 11922250
    [No Abstract]   [Full Text] [Related]  

  • 37. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.
    Snounou G; White NJ
    Trends Parasitol; 2004 Jul; 20(7):333-9. PubMed ID: 15193565
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.
    Koepfli C; Mueller I; Marfurt J; Goroti M; Sie A; Oa O; Genton B; Beck HP; Felger I
    J Infect Dis; 2009 Apr; 199(7):1074-80. PubMed ID: 19275476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.